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Abstract.  Previous studies of neural cell adhesion 
molecule (NCAM) cDNAs have revealed an alterna- 
tively spliced set of small exons (12A,  12B,  12C,  and 
12D) that encode a  region in the extracellular portion 
of the molecule known as the muscle-specific domain 
(MSD). The entire MSD region can be expressed in 
skeletal muscle, heart,  and skin; only exons  12A and 
12D have been found in brain.  These studies did not 
reveal which NCAM polypeptides contain the MSD 
region or the immunohistochemical  distribution of 
these NCAM molecules. To address these questions, 
we prepared antibodies against the oligopeptides en- 
coded by exons 12A and  12B and by exons  12C and 
12D,  and we used these antibodies to study the forms 
of NCAM containing the MSD region expressed dur- 
ing embryonic chicken heart development.  These anti- 
bodies recognize certain forms of NCAM found in the 
heart,  but they do not recognize brain NCAM. In the 
heart,  each of the splice variants of NCAM (large cy- 
toplasmic domain,  small cytoplasmic domain,  and 
small surface domain) that differ in their mode of at- 
tachment to the plasma membrane or in the size of 
their cytoplasmic domain is expressed in a form that 
contains and in a form that lacks the MSD region.  No 
microheterogeneity is observed in the size of NCAM 
molecules containing the MSD region, even at the 
level of cyanogen bromide fragments,  suggesting that 
exons  12A-D are expressed as a  single unit.  Depend- 
ing on the site and the stage of development, the 
percent of NCAM molecules containing the MSD re- 
gion can vary from nearly 0 to  100%.  In general, this 
percentage increases during development. In immuno- 
histochemical studies of hearts from stage 18 embryos, 
forms of NCAM containing the MSD region colocal- 
ized with Z discs.  No other adhesion molecules were 
found in this distribution at this early stage of devel- 
opment.  Studies on isolated cells in vitro demonstrate 
that the colocalization with Z  discs of NCAM mole- 
cules containing the MSD region does not depend on 
cell-cell contact, and they raise the possibility that 
this form of NCAM is involved in cell-extracellular 
matrix interactions.  The association of NCAM mole- 
cules containing the MSD region with Z  discs sug- 
gests that this form of NCAM is involved in early 
myofibrillogenesis. 
H~SION molecules are  important  in  the  control  of 
cell  behavior  during  development  both  directly 
through  their  roles in mediating  cell migration  and 
the  maintenance  of tissue  borders,  as  well  as  indirectly 
through the transmembrane signal transduction  mechanisms 
their binding  initiates  (Takeichi,  1990; Edelman and Cros- 
sin,  1991; Hynes, 1992; Damsky and Werb,  1992; Juliano 
and Haskill,  1993). There are many stages in early heart de- 
velopment when changes  in the expression  or function  of 
cell-cell adhesion  molecules (CAMs)  ~ may mediate or sta- 
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adhesion molecule; OTG, octylthioglucopyranoside;  PIPLC, phosphatidyl- 
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bilize changes in morphology or may influence other develop- 
mental  processes.  The  primitive  heart  (precardiac  meso- 
dermal epithelium)  appears as paired primordia (Romanoff, 
1960; Carlson, 1981). NCAM and N-cadherin are expressed 
on almost all of these cells (Crossin and Hoffman,  1991; Li- 
nask, 1992). Some of these precardiac cells deadhere as they 
downregulate  expression  of these adhesion  molecules,  con- 
vert into mesenchymal  cells, and migrate  into the basement 
membrane.  The primordia then  fuse to form one double- 
layered tube consisting of an inner and outer epithelium (the 
endocardium and myocardium,  respectively)  separated by a 
middle acellular basement membrane known as the cardiac 
jelly. The endocardium is derived from the cells that have un- 
dergone an epithelial-mesenchymal  transformation,  which 
then convert back to epithelium. 
The transformation  of the heart from a simple  tube to a 
four-chambered structure containing  valves and the appro- 
priate connections  to the rest of the circulatory system in- 
volves'a  second  epithelial-mesenchymal  transformation. 
This transformation  is region specific; it results in the growth 
of the endocardial  cushion tissue (ECT) in the atrioventricu- 
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tricle (Markwald et al.,  1984).  The ECT arises from cells 
of the endocardial endothelium that deadhere, convert into 
mesenchymal  cells, and migrate into the cardiac jelly (Mark- 
wald et al., 1978).  Neural cell adhesion molecule (NCAM) 
is  continuously  expressed on all  cells  of  the  myocardium and 
endocardial endothelium;  in contrast, N-cadherin  is ex- 
pressed only in  the myocardium at  this  stage  of  heart  devel- 
opment (Linask, 1992). Concomitantly with their  dcadhc- 
sion, migrating ECT  ceils  downregulate  their expression 
of NCAM  (Mjaatvedt and Markwald,  1989; Crossin and 
Hoffman,  1991) as assayed immunohistochemicaLly.  It re- 
mains to be demonstrated, however, whether the levels  of 
NCAM  protein actually decrease or whether NCAM  be- 
comes masked so that  it  is not immunohistochemically  de- 
tectable.  Later in development, the growing cushion tissue 
pads fuse in a manner that subdivides the flow of blood 
through the  heart  into  two channels.  It  is  likely  that  the  regu- 
lation  of  CAM  expression  or  function  plays  a role  in  mediat- 
ing this sequence of deadhesion  and adhesion that occur 
during the epithelial-mesenchymal transformation and the 
fusion of cushion tissue  pads. 
NCAM,  the first  adhesion molecule to bc identified  as a 
member of  the  IgG superfamily,  is  a  cell  surface  glycoprotein 
that  contains  large  amounts of  polysialic  acid  (Cunningham 
ctal., 1987). Several  variant  forms of  NCAM  are produced 
by alternative  mRNA  splicing  from a single  gene. The best 
known of  these  variants  are three  forms of  brain  NCAM  that 
differ in their attachment to the plasma membrane.  One 
form, small  surface  domain (ssd),  is  covalently  linked  to  the 
glycolipid  glycosyl-phosphatidylinositol  (GPI); two integral 
membrane forms, large  cytoplasmic domain (Id)  and small 
cytoplasmic domain (sd),  differ  in  the size  of  their  cytoplas- 
mic domains (Hemperly et al.,  1986; Murray et al.,  1986; 
He et al., 1986). In addition, small inserts have been 
identified  at  two distinct  sites  in the extracellular  portion  of 
the  molecule. The variable  domain alternatively  spliced  exon 
(VASE) insert  is  present  between the sequences encoded by 
cxons 7 and 8, and it is found in both the brain and heart 
(Small et  al.,  1987;  Small and Akeson, 1990). The so-called 
muscle-specific domain (MSD) region is encoded by four 
small  exons (12A, 12B, 12C, and 12D) that  are  localized  be- 
tween exons 12 and 13 (Prediger  et  al.,  1988; Thompson et 
al., 1989), and that  appear to be expressed in a variety  of 
splice  combinations (Reyes et al.,  1991).  This region is lo- 
cated  between two consecutive  fibronectin  type  HI repeats  in 
NCAM  and  contains site(s) for O-linked  glycosylation 
(Walsh et  al.,  1989). From this  region,  only exons 12A and 
12D are expressed in  the brain  (Santoni et  al.,  1989; Ham- 
shere et al., 1991; Reyes et al., 1993); all four of these small 
exons are present in heart, skeletal muscle, and skin (Dick- 
son et al.,  1987; Prediger et al.,  1988;  Marsh and Gallin, 
1992). While the sequence of  these four small exons is highly 
conserved between humans, rats, and mice, two of the four 
chicken exons (12A and 12B) are very different in sequence 
from their mammalian counterparts (Prediger et al,  1988). 
NCAM mediates cell-cell adhesion both by a homophilic 
mechanism (Rutishauser et al.,  1982;  Hotfman and Edel- 
man, 1983; Sadoul et al., 1983), i.e., NCAM to NCAM, and 
by a heterophilic mechanism involving the interaction of a 
heparin-binding domain in NCAM with heparan sulfate pro- 
teoglycans (Reyes et al., 1990). Binding experiments on the 
homophilic mechanism have revealed that the absolute level 
of expression  of NCAM  and  differential polysialylation 
strongly affect its adhesive strength (Hoffman and Edelman, 
1983).  Functional studies on splice variants of NCAM sug- 
gest that the expression of the VASE insert inhibits neurite 
outgrowth, while the MSD region had no effect in these ex- 
periments (Doherty et al.,  1992).  Recent experiments sug- 
gest that the MSD region plays a  role in myoblast fusion 
(Peck and Walsh, 1993). Possible functions for the MSD re- 
gion may be related to the fact that it contains an O-linked 
carbohydrate acceptor site (Waish et al.,  1989).  The mode 
of association of NCAM with the cell surface may also have 
functional consequences. Because the ssd form of NCAM is 
targeted to the apical surface of polarized epithelial cells 
(powell et al., 1991), it is possible that this form of NCAM 
may be localized to the luminal surface of the endocardial 
endothelium. Recent studies  suggest that transmembrane 
forms of NCAM promote myoblast fusion (Peck and Walsh, 
1993) and downregulate the secretion of a 92-kD gelatinase 
(Edvardsen et al.,  1993);  the GPI-linked form of NCAM 
does not have these effects. 
In the current study, we have prepared antibodies against 
two oligopeptides that together comprise the MSD region of 
chicken NCAM. These antibodies have been used to analyze 
the expression of forms of NCAM in the developing heart. 
We find that the ld, sd, and ssd forms of NCAM all can be 
expressed either containing or lacking the MSD region, that 
these six forms of NCAM change in their temporal and spa- 
tial patterns of expression during development, and that at 
the protein level, there is no evidence for differential splicing 
among the small exons 12A, 12B, 12C, and 12D. Most strik- 
ingly, we find that forms of NCAM containing the MSD re- 
gion are colocalized with Z discs, suggesting a role for this 
region in myofibrillogenesis. 
Materials and Methods 
Materials 
Reagents  were  purchased  from  the  following  sources:  keyhole  limpet 
hemocyanin (KLH), Calbiochem-Novabiochem Corp.  (San Diego,  CA); 
N-succinimidyl  3-(2-pyridyldithio)propionate  end bicinchoninic acid pro- 
tein assay kit, Pierce Chemical Co. (lh~kfDrd, IL); reagents for gel elec- 
trophoresis and Western blotting, BioRad Laboratories (Hercules,  CA); 
leupeptin, Boehringer Mannheim Biochemicals (Indianapolis,  IN); neur- 
anfufidase f~om Streptococcus sp. (catalogue No. 151738; ICN Biomedicals, 
Inc., Costa Mesa, CA); DE 52, Whalman Lab Sales Inc. (HiUsboro, OR); 
cyanogen bromide (CNBr), Aldrich Chemical Co. (Milwaukee,  WI). All 
other reagents were obtained from Sigma Chemical Co. (St. Louis, MO). 
Antibodies 
Anti-NCAM. NCAM from 14-d embryonic chicken brains, purified as de- 
scribed below or as previously described (Hoffman et al., 1982), was used 
to immunize rabbits. This antibody is frequently referred to as the pan- 
NCAM antibody because it recognizes all forms of NCAM. 
Anti-12AB and Anff-12CD.  Two peptides that together comprise the 
MSD region in chicken NCAM (Prediger et al., 1988) were synthesized by 
the Medical University of South Carolina Protein Sequence Facility. Oligo- 
peptide 12AB contains the sequence encoded by exons 12A end 12B (single 
letter code RIPHSPSAAAZICLAE); oligopeptide  12CD contains the se- 
quence encoded by exons  12C and 12D (TI~PLPASESTEPPKG).  Each 
peptide was synthesized with two additional cysteine residues at its COOH- 
terminal. To induce strong immunogenicity,  each oligopeptide  was con- 
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duced using 100 mM DTT for 30 win, and the peptides  were desalted on 
G-25 Sephadex equilibrated in 0.1 M sodium phosphate/O.1 M NaCI,  pH 
7.5. KLH was desaited using this same buffer, then activated with SPDP at 
a molar ratio of 1:2,500 for 1 h, then desalted again. Finally, the reduced 
oligopeptides were incubated with the activated KLH at a 500:1 molar ratio 
for 1 h, then desaited. These oligopeptide-KLH  conjugates  were dialyzed 
against water,  lyophilized,  and resuspended in PBS. 
Inoculations (50/~g NCAM or 1 mg oligopeptide-KLH  conjugates per 
rabbit per injection) were performed, and IgG was purified from serum by 
standard methods (Thiery et al.,  1977). 
Monoclonal antibodies 4d (specific for the Id form of NCAM), V2E9, 
and JG22 (each specific for the ~-integrin subunit) were obtained from the 
Developmental Studies Hybridoma Bank (Iowa City, IA). Monoclonai anti- 
body NCD-2 (specific for N-eadharin) was a gift from Dr. Jack Lilian (Clem- 
son University, Clemson, SC). Monoclonal antibodies against vincuiin and 
a-actinin (sareomeric)  were obtained from Sigma Chemical Co. (product 
Nos.  V-9131 [clone hVIN-1] and A-7811 [clone EA-53],  respectively). 
Western Blots 
Samples  were resolved  by SDS-PAGE  under  reducing  conditions  on 
minigels  containing  6  %  acrylawide,  except  in the experiment on CNBr 
fragments  of  NCAM, in  which 12% acrylamide  was  used  and  uonreducing 
conditions  were  used  to  enhance  antigenicity.  Proteins  were  transblotted  to 
nitrocellulose  using  a  semidry  transfer  method (Trans-Blot  Semi-Dry  Elec- 
trophoretic  Transfer  Cell;  BioRad). The nitrocellulose  was blocked,  in- 
cubated  with  primary  antibodies,  incubated  with  secondary  antibodies  (goat 
anti-rabbit  or anti-mouse IgGs conjugated  to alkaline  phosphatase),  and 
color  developed  using  bromochloroindoyl  phosphate  and  nitroblue  tetrazo- 
llum as described  by BioRad. 
Preparation of  Membranes/NP-40 Extraction/ 
Neuraminidase Treatment/Phosphatidylinositol-specific 
Phospholipase C (PIPLC) Digestion 
Purified membranes were prepared from 14-d embryonic chicken brains 
and 14-d embryonic and adult chicken  hearts. Brains in cold PBS containing 
protease  inhibitors (N-ethylmaieimide,  10  raM;  benTamidine,  5  raM; 
leupeptin, 50 t~g/ml; aprotinin, 2 ttg/ml; phenylmcthylsulfonylflnoride,  2 
raM; pepstatin A, 5 ~g/wi) were homogenized using an ultrasonic generator 
(Sonic 2000U; Braun Biotech International, Allentown, PA). Homngenates 
were overlaid on PBS containing 42%  sucrose,  then ultracentrifuged at 
100,000 g for 30 win at 4°C. The membrane fraction that appeared above 
the 42 % sucrose was harvested, washed by dilution with cold PBS, and col- 
lected by centrifugation at 8 krpm for 20 rain in a rotor (JA10; Beckman 
Instruments, Inc., FuUerton,  CA) in a Beckman J2-HS  high speed cen- 
trifuge.  For heart membrane preparation, tissue was sonicated in ice-cold 
hypotonic buffer (200 mM sucrose/5 mM sodium phosphate, pH 7.5/1 mM 
EGTA) in the presence of protease inhibitors. Low speed centrifugation, 
300 g for 10 rain, separated the membranes from nuclei and large debris. 
Membranes in the superuatant were then collected by uitracentrifugation  at 
100,000 g for 30 rain. 
Crude  membranes were prepared  from 4-,  7-,  and  lO-d  embryonic 
chicken hearts and 5-d embryonic chicken ventricles and cushion tissue 
pads. Tissue in PBS was homogenized in the presence ofprotease inhibitors, 
then washed  with PBS  and harvested by two  rounds of centrifngation 
(14,000 rpm for 3 mill) in a microfuge. 
To prepare NP-40 extracts for Western blotting  and peanut lectin chroma- 
tography, membranes were pelleted in a microfuge (14,000 rpm for 3 rain), 
resuspended in 10 vol of 0.5 % NP-40/PBS,  and the extracts clarified in the 
microfuge (14,000 rpm for 5 win). The protein content of NP-40 extracts 
was quantitated using the BCA assay. 
To  treat membranes with  neuramim'dase,  pelleted  membranes  were 
resuspended in 3 vol of PBS containing 0.3  U/WI of neuraminidase, in- 
cuhated for 1 h at 37°C, then washed with PBS and harvested by centrifuga- 
tion. To neuraminidase treat NP-40 extracts,  neuraminidase was added to 
NP-40 extracts to a final 0.3 U/ml and incubated for 1 h at 37°C. 
To PIPLC digest membranes, pelleted membranes were resuspended in 
3 vol of PBS containing 0.02 U/ml of PIPLC (from Bacillus cereus, Sigma 
catalogue No.  P  8804), incubated for 30 win at 37°C,  and the PlPLC- 
released molecules in the supernatant were harvested by centrifugation in 
a microfuge (14,000 rpm for 3 rain). The residual membrane pellet was NP- 
40 extracted  as described above. 
Immunoprecipitation of  NCAM Molecules Containing 
the MSD Region 
Purified membranes from 14-d embryonic chicken hearts (50 ~1 packed vol- 
ume) were resnspended in 0.5 rnl PBS containing 1 mg/ml anti-12AB or 
anti-12CD  IgG and incubated for 1 h at 4°C with agitation. Membranes 
were washed with PBS and harvested by two rounds of centrifugation in a 
microfuge (14,000 rpm for 3 rain). The membranes were extracted with NP- 
40 as described above, and antigen-antibody  complexes  were collected by 
incubation with 50 ~1 of protein A-Sepharose for 1 h at 4°C. The beads were 
then washed several times with 0.5% NP-40/PBS. Bound NCAM was eluted 
by boiling the beads in SDS-PAGE sample buffer and Western blotted using 
the pan-NCAM antibody as the primary antibody for detection. This pro- 
cedure allowed  immunoprecipitation experiments to be performed using 
anti-12AB and anti-12CD. Immunoprecipitation experiments that were per- 
formed with these antibodies, in which the antibodies were added to pro- 
teins that had already  been NP-40  extracted,  gave  uniformly negative 
results. 
Peanut Lectin Chromatography 
1.5 ml of NP-40 extract from purified membranes from 14-d embryonic 
chicken hearts was incubated with 50 ~1 of peanut lectin-agarose (Sigma 
catalogue No. L 2507) for I h at 4°C with agitation. The beads were then 
washed  several  times with 0.5%  NP-d0/PBS,  and bound proteins were 
eluted with 0.5 ml of 0.5%  NP-40/PBS/0.1  M galactose. 
Purification of NCAM/CNBr Digestion 
Packed brain or heart membranes were resuspended in 10 vol of 0.I M Tris 
base to elute weakly  attached proteins.  Membranes were collected by 
ultracentrifugation and extracted in 10 vol of 0.5%  NP-40/0.2  M sodium 
phosphate, pH 6.3, containing protease inhibitors. Extracts were clarified 
by ultracentrifugetion and applied to DE 52 eqnilibriated in 0.5% NP-40/ 
0.2 M sodium phosphate, pH 6.3 (10 wi of extract per ml of beads). The 
column was washed with 0.2 M sodium phosphate, pH 6.3, until no NP-40 
could be detected in the eluate.  Contaminants were then eluted with 1 M 
NaCI/20 mM sodium phosphate, pH 6.5. The colunm was then washed with 
25 mM octylthinglucopyranoside  (OTG)/20 mM sodium phosphate, pH 6.5. 
Finally, NCAM was ehited from the DE 52 using 0.55  M  NaCl/25 mM 
OTG/20 raM sodium phosphate, pH 6.5. The eluate was dialyzed versus wa- 
ter and lyophilized.  NCAM was further purified by HPLC gel filtration on 
a column (G4000SW;  TosoHAAS,  Philadelphia, PA) equilibrated with 25 
mM OTG/20 mM sodium phosphate, pH 6.5. This procedure yielded brain 
NCAM that was essentially 100% pure, as evaluated by SDS-PAGE,  and 
heart NCAM that was '~30% pure. 
Purified NCAM was dialyzed versus water, adjusted to a final 70% for- 
mic acid, and treated with a large excess of CNBr under N2 overnight, then 
dried in a Speed-Vac (Savant Instrument, Inc., Hicksville,  NY). This mate- 
rial was then dissolved in a small volume of 25 mM OTG/PBS and neur- 
aminidase treated as described above. 
Immunohistochemistry 
Hamburger and Hamilton (1951) stage  18 chicken embryos were briefly 
rinsed in PBS and placed in plastic molds with Tissue-Tek compound media 
(ICN Biomedicals).  Samples were quick frozen using liquid nitrogen. 5-/~m 
frozen sections were cut and mounted on poly-L-lysine-coated  slide glasses. 
After riming off the embedding medium with distilled water and PBS, the 
sections were incubated at room temperature with 10% normal goat se- 
rum/PBS for 30 rain to block nonspecific binding. Sections were incubated 
with primary antibodies (25 t~g/ml for rabbit  antibodies, 10 ttg/wi for mono- 
clonai antibodies, except for antivincuiin and anti-a-actinin, which were 
used at 1:400 and 1:800 dilutions, respectively,  as per the manufacturer's 
instructions) in 1% BSA/PBS in a humid chamber at 4°C for 4-16 h, then 
rinsed with 1% BSA/PBS.  Appropriate fluorescein-conjugated  secondary 
antibodies (10 ~g/wi of goat anti-rabbit IgG or goat anti-mouse IgG [Orga- 
non Teknika Corp., Durham, NC] in 1% BSA/PBS) were applied for l h, 
followed by rinsing and mounting in 90% glycerol,  0.2 M n-propyl gailate 
(Giloh and Sedat,  1982). Stained sections were examined by epifluoreseent 
illumination using an Axioscope (Carl Zeiss, Inc., Thoruwood,  NY). 
Two experiments were performed to verify that the only molecules rec- 
ognized  by anti-12CD  are NCAM molecules containing the peptide se- 
quence used as an immunogen.  In one, the diluted antibody (25 ttg/ml) was 
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Figure I. Schematic model of forms of NCAM produced by alter- 
native  mRNA splicing  in the  MSD  and  membrane attachment 
regions.  Exon numbers  encoding  the various  regions  within the 
molecule are indicated. Id, sd, and ssd forms differ in their attach- 
ment to the membrane through the expression of transmembrane 
and cytoplasmic exons 16, 17, 18, and 19, or through the'expression 
of exon 15 encoding a peptide that becomes covalently linked to 
GPI. The MSD region comprised of  exons 12A, 12B, 12C, and 12D 
is expanded,  and the sequences of the peptides  from this region 
used to immunize rabbits are shown in single-letter code. 
preabsorbed by mixing with 1.25 #g/mi of the immunogenic peptide for 30 
rain at room temperature, followed by clarification at 13,000 g. In the sec- 
ond, tissue sections were preincubated with the pan-NCAM antibody (25 
#g/mi) for 4 h before the addition of  anti-12CD (25 #g/ml). Both treatments 
completely blocked anti-12CD staining. 
To examine the distribution of  anti-12CD staining in cultured cells, cells 
were released from stage 18 hearts as described by Krug et al. 0987) and 
depleted of  fibroblasts as described by Lau (1994). The enriched cardiomyo- 
cytes were plated on slides coated using a 20 #g/nil solution of flbronectin 
Figure 3. Forms of NCAM in 7-d embryonic heart tissue. As de- 
scribed in Materials  and Methods, NP-40 extracts of membranes 
were neuraminidase treated, then Western blotted using antibodies 
specific for the indicated antigens as the primary antibodies for de- 
tection  (180 kD  indicates  the  use  of monoclonal  antibody  4<1 
specific for the ld form of  NCAM). Lanes containing 7-d embryonic 
heart exact (tit) were loaded with 5 #g of  protein for detection with 
the pan-NCAM antibody or 4d and with 15 #g of protein for detec- 
tion with anti-12AB or anti-12CD. The lane containing  14-d em- 
bryonic brain extract (Br) was loaded with  1 #g of protein.  The 
185- and 180-kD forms of heart NCAM recognized by 4d are indi- 
cated. 
(New York Blood Center, New York) and incubated for 3-7 d in the "com- 
plete M199 medium" of  Kruget al. (1987). Cells were fixed with cold meth- 
anol (10 rain,  -20°C), then rinsed briefly with 50% methanol/50% PBS 
followed by a PBS rinse. Cells were stained as described above and exam- 
ined by confocal  microscopy. 
Confocal Microscopy 
As described above, 10-#m frozen sections were prepared and stained with 
anti-12CD  as  the  primary  antibody  and  with  FITC-conjugated  goat 
anti-rabbit IgG as the secondary antibody. The sections were then double 
stained by further incubation with either monoclonal anti-~-actinin (sarco- 
meric)  followed by rhodamine  isthiocyanate-conjugated goat anti-mouse 
IgG or the pan-NCAM antibody followed by rhodamine isthiocyanate-con- 
jugated goat anti-rabbit IgG. Stained sections were examined by confocal 
microscopy using a BioRad MRC-1000 Laser Scanning Confocal Imaging 
System equipped with a Zeiss Axioscope. The confocal iris was set at the 
smallest value to obtain the thinnest possible optical sections (<0,25 #m). 
Figure 2.  Specificity of antibodies  against  the  MSD  region  of 
NCAM.  As described  in Materials  and Methods,  NP-40 extracts 
from 14-d embryonic  chicken  heart  and brain membranes were 
neuramiuldase treated, then Western blotted using antibodies pre- 
pared against the indicated antigens as the primary antibodies for 
detection.  Lanes containing  heart extract  (Ht) were loaded with 
5 #g of protein for detection with the pan-NCAM  antibody and 15 
#g of  protein for detection with anti-12AB or anti-12CD; lanes con- 
raining brain extract (Br) were loaded with 1 ~tg of protein for de- 
tection with the pan-NCAM antibody and 3 #g for detection with 
anti-12AB or anti-12CD. This 5:1 heart extract/brain  extract ratio 
results  in similar  levels of total NCAM  detected  with  the  pan- 
NCAM antibody. The four forms of  heart NCAM rvcogniz~ by the 
pan-NCAM  antibody  (155, 145, 125, and  120 kD) and the two 
forms of  heart NCAM recognized by anti-12AB and anti-12CD (155 
and  125 kD) are indicated. The migration of standard proteins is 
indicated by their relative molecular masses ×  10  -3. 
Results 
Antibodies Specific for the MSD Region in NCAM 
A  subset of NCAM molecules from skeletal muscle, heart, 
and skin contain a polypeptide sequence that is encoded by 
a  series of four small alternatively spliced exons (12A-D) 
(Dickson et al., 1987; Prediger et al., 1988; Marsh and Gal- 
lin,  1992).  This  portion  of the  molecule  was  originally 
(Dickson et al.,  1987)  named the muscle-specific domain; 
this nomenclature will be used here. The localization and se- 
quence of this region of NCAM is shown in Fig.  1. 
Two antibodies were prepared against the MSD region of 
NCAM; one (anti-12AB) against the polypeptide encoded by 
exons 12A and 12B, the second (anti-12CD) against the poly- 
peptide encoded by exons 12C and 12D (see Materials and 
Methods for details of antibody production). The ability of 
these antibodies to recognize brain and heart NCAM in ex- 
tracts from 14-d embryos was compared to that of antibodies 
prepared  against  the  entire  NCAM  molecule  (Fig.  2). 
Whereas the pan-NCAM antibody recognizes all forms of 
NCAM present in brain or heart, anti-12AB and anti-12CD 
recognize only heart NCAM.  Moreover, only two (155 and 
125 kD) of the four forms of heart NCAM recognized by the 
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scribed  in Materials  and  Methods,  14-d embryonic  heart  mem- 
branes were neuraminidase treated, treated with PIPLC to release 
GPI-linked proteins,  and the residual membranes  were extracted 
with NP-40. NP-40 extracts (5 #g for detection with the pan-NCAM 
antibody; 15 #g for detection with anti-12CD) and PIPLC-released 
material (from equivalent amounts of membranes as the NP-40 ex- 
tracts) were Western blotted using antibodies prepared against the 
indicated antigens as the primary antigens for detection.  The four 
forms (recognized by the pan-NCAM antibody) of heart NCAM in 
NP-40 extracts (155, 145, 125, and  120 kD) and the two PIPLC- 
releasable forms of heart NCAM (125 and 120 kD) are indicated. 
pan-NCAM antibody at this stage of development (155, 145, 
125, and 120 kD) are recognized by anti-12AB and anti-12CD. 
The specificities of anti-12AB and anti-12CD were also ex- 
amined in extracts of 7-d embryonic hearts (Fig. 3) in which 
six forms of NCAM are detected using the pan-NCAM anti- 
body (185 and 180 kD, in addition to the four forms observed 
in 14-d heart extracts). Anti-12AB and antiq2CD recognized 
the 185-kD form, as well as the two forms recognized in 14-d 
extracts. 
ld, sd, and ssd Forms of NCAM AU Can Contain the 
MSD Region 
Three  forms  of  NCAM  (Cunningham  et  al.,  1987)  are 
defined by their mode of attachment to the plasma membrane 
(Fig.  1). Two forms, ld and sd, are transmembrane proteins 
containing  large  and  small  cytoplasmic domains,  respec- 
tively. The third form, ssd, is GPI linked to the plasma mem- 
brane, ld NCAM has a molecular mass of ~180 kD and had 
previously been observed conclusively only in neural  tis- 
sues.  To determine whether the  185- and  180-kD forms of 
NCAM  observed in  7-d embryonic heart are  authentic  ld 
NCAM,  extracts  were  Western  blotted  (Fig.  3)  using  a 
monoclonal antibody (4d; Watanabe et al., 1986) specific for 
this form of NCAM.  Both the  185- and  180-kD forms of 
heart NCAM, as well as a form of brain NCAM of similar 
molecular mass, were recognized by this antibody.  These 
results indicate that two forms ofld NCAM (185 and 180 kD) 
are present  in  these heart  extracts,  and  that  one  of these 
forms (185  kD) also contains the MSD region. 
To determine which of the forms of NCAM we observe are 
GPI linked to the plasma membrane, membranes from 14-d 
Figure 5. MSD region in CNBr digests of NCAM. As described in 
Materials and Methods, NCAM was purified from 14-d embryonic 
brain and heart membranes,  digested with CNBr, neuraminidase 
treated, and Western blotted using antibodies prepared against the 
indicated antigens as the primary antibodies for detection.  Lanes 
containing brain NCAM CNBr fragments (Br)  were loaded with 10 
~tg of protein for detection with the pan-NCAM antibody and 30 
#g of  protein for detection with anti-12AB or anti-12CD; lanes con- 
raining heart NCAM CNBr fragments (Ht) were  loaded with 30 #g 
of protein for detection with the pan-NCAM antibody and 90 #g 
of protein for detection with anti-12AB or anti-12CD. This ratio of 
brain and heart NCAM CNBr fragments was chosen to provide 
similar levels of signal using the pan-NCAM antibody for detec- 
tion. The migration of standard proteins is indicated by their rela- 
tive molecular masses  x  IO-L 
embryonic heart tissue were treated with PIPLC to release 
the GPI-linked forms. NP-40 extracts of the residual mem- 
branes (Fig. 4 A) or the PIPLC-released material (Fig. 4 B) 
were then Western blotted with either the pan-NCAM anti- 
body  or  anti-12CD.  Only the  125-  and  120-kD  forms of 
NCAM were released by PIPLC, and of these, only the 125- 
kD  form was recognized by anti-12CD.  As in  Fig.  2,  the 
155-,  145-,  125-,  and 120-kD forms of NCAM were present 
in the residual membranes, of which only the 155- and 125- 
kD forms were recognized by anti-12CD.  Thus, it appears 
that the  185- and 180-kD forms of NCAM are ld, the  155- 
and  145-kD forms are sd, and the  125- and  120-kD forms 
are ssd. In each pair, there is a higher molecular mass spe- 
cies containing the MSD region and a lower molecular mass 
species lacking the MSD region. 
The MSD Region Does Not Show Heterogeneity 
in Molecular Weight 
PCR amplification studies of rat heart cDNAs suggested that 
alternative splicing occurs among exons 12A-D that should 
lead to multiple forms of NCAM with MSD regions of differ- 
ent sizes (Reyes et al.,  1991).  In contrast, our results show 
no evidence for size heterogeneity in the MSD regions of ld, 
sd, or ssd NCAM from either 7-d or 14-d embryonic hearts 
(Figs. 2--4). To evaluate whether we do not observe size het- 
erogeneity because the differences in the sizes of the variants 
are small compared to the size of'the intact NCAM mole- 
cule,  CNBr fragments of heart NCAM were prepared and 
Western blotted with the pan-NCAM antibody, anti-12AB, 
and anti-12CD (Fig. 5). As expected from the localization of 
the MSD region within NCAM (Dickson et al., 1987), anti- 
12AB and anti-12CD recognized a single CNBr fragment of 
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anti-12AB  and  anti-12CD.  (.4) Western  blots:  as  described  in 
Materials  and Methods,  NP-40 extracts of 14-d embryonic heart 
membranes (15/~g aliquots) either without (-) or with (+) neur- 
amim'dase treatment were Western blotted using antibodies against 
the indicated antigens as the primary antibodies for detection. (B) 
Immunoprecipitation:  as  described  in  Materials  and  Methods, 
NCAM  from  14-d embryonic  heart plasma membranes,  either 
without (-) or with (+) neuraminidase treatment, was immunopre- 
cipitated using anti-12CD IgG. This material was Western blotted 
using the pan-NCAM antibody as the primary antibody for detec- 
tion. Similar results were obtained in immunoprecipitation experi- 
ments using anti-12AB IgG (data not shown). The heavy band near 
the bottom of  both lanes represents IgG heavy chain. The migration 
of the 155- and 125-kD forms of NCAM containing the MSD re- 
gion is shown in both A and B. 
l~gure 7. Binding of NCAM to immobilized peanut lectin. As de- 
scribed  in  Materials  and  Methods,  NP-40 extracts  of 14-d em- 
bryonic heart membranes, either untreated (-) or treated (+) with 
neuraminidase,  were  incubated  with peanut  lectin-agarose.  Ali- 
quots of the total extract (T) and the 0.1-M galactose eluate (E) 
were Western blotted using antibodies against the indicated anti- 
gens as the primary antibodies for detection. Lanes containing total 
extract were loaded with 5 ttg of  protein for detection with the pan- 
NCAM antibody and with 15/tg of protein for detection with anti- 
12AB or anti-12CD;  lanes  containing  the galactose  eluate  were 
loaded with the material purified from 20/~g of  extract for detection 
with the pan-NCAM antibody and with the material purified from 
60 ~g of extract for detection  with anti-12AB or anti-12CD. The 
migration  of the  155- and  125-kD  forms of NCAM  that  are 
specifically  precipitated  by  immobilized  peanut  lectin  and  are 
specifically recognized by anti-MSD  region  antibodies  are indi- 
cated. 
~,45 kD. No size heterogeneity in the MSD region was seen, 
even  in  these  CNBr  digests.  In  control  experiments,  no 
CNBr fragments of brain NCAM were recognized by either 
anti-12AB or anti-12CD, even though the profiles of CNBr 
fragments of brain and heart NCAM recognized by the pan- 
NCAM antibody were similar. These results indicate that, at 
the protein level, only one form of the MSD region can be 
detected in our extracts, presumably that encoded by mRNAs 
containing the transcripts from all of exons 12A,  12B,  12C, 
and  12D. 
Polysialic Acid on NCAM Inhibits 
the Ability of  Anti-MSD Antibodies 
to Recognize the Molecule 
NCAM molecules bear unique, massive polysialic acid-con- 
taining oligosaccharide(s) in close proximity to the MSD re- 
gion (Cunningham et al.,  1987). To determine whether this 
structure interferes with the ability of anti-MSD region anti- 
bodies to bind to the molecule, the ability of anti-12AB and 
anti-12CD to recognize NCAM molecules before and after 
neuraminidase treatment was compared (Fig.  6).  Whereas 
polysialic acid does not interfere with the ability of the pan 
NCAM antibody to recognize NCAM, anti-12AB and anti- 
12CD do not recognize NCAM in Western blots (Fig. 6 A) 
or by immunoprecipitation (Fig. 6 B) unless the polysialic 
acid is first removed from the molecule. Interestingly, anti- 
12CD does recognize NCAM equally well before and after 
neuraminidase  treatment  in  immunohistochemical  experi- 
ments (data not shown). 
Forms of NCAM Containing the MSD Region Also 
Bind to Peanut Lectin 
NCAM from a skeletal muscle cell line consists of a 155-kD 
transmembrane  form that  contains  the  MSD  region  and 
binds to peanut lectin and a  125-kD GPI-linked form that 
does not contain the MSD region and does not bind to peanut 
lectin (Walsh et al.,  1989). To characterize the peanut lectin 
binding  of heart NCAM,  NP-40 extracts of plasma mem- 
branes from 14-d embryonic heart tissue were fractionated 
on immobilized peanut lectin; the forms of NCAM in the to- 
tal and eluate were then detected by Western blotting with 
the pan-NCAM antibody,  anti-12AB,  and anti-12CD  (Fig. 
7). NCAM molecules bind to peanut lectin only after neur- 
aminidase treatment;  even then,  only the two polypeptides 
(155 and  125  kD) recognized by anti-12AB and anti-12CD 
bind to peanut lectin.  These results are consistent with the 
facts that peanut-lectin binding oligosaccharides are believed 
to be O-linked and that the MSD region contains two puta- 
tive acceptor sites for O-glycosylation. 
Dewlopmentai Changes in the Expression of  Forms 
of  NCAM 
The forms of NCAM present in extracts from 4-, 7-, 10-, and 
14-d embryonic heart tissue and adult heart tissue were com- 
pared (Fig. 8). Dramatic shifts were observed in the expres- 
sion of ld, sd, and ssd NCAM, as well as in the proportions 
of  each of these forms containing the MSD region, ld NCAM 
was present at 4 d, peaked at 7 d, was still present at 10 d, 
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scribed in Materials and Methods, 5-#g aliquots of NP-40 extracts 
of membranes from 4-d (lane 4), 7-d (lane 7), 10-d (lane IO), and 
14-d (lane 14) embryonic heart tissue, and from adult (A) heart tis- 
sue were ueuramim'dase treated,  then Western blotted using the 
pan-NCAM antibody as the primary antibody for detection. The 
migrations of the 185-, 180-, 155-, 145-, 125-, and 120-kD forms 
of NCAM are indicated, those containing the MSD region (185, 
155, and 125 kD) are in bold. The identity of  these forms of  NCAM 
was confirmed in parallel experiments using anti-12AB and anti- 
12CD for detection (data not shown). The migration of standard 
proteins is indicated by their relative molecular masses  ×  10  -3. 
but was  absent thereafter.  The sd  form of NCAM  is  ex- 
pressed in a similar time course as ld, while the ssd is ex- 
pressed later in development and is essentially the only form 
observed in adult tissue. 
The ratio of MSD positive to MSD  negative  forms of 
NCAM  varies  during  development.  For  ld,  sd,  and  ssd 
NCAM,  the  percentage  of the  molecules  containing  the 
MSD region always increases during development (Fig. 8). 
For example, in 7-d tissue, the MSD-positive 185- and 155- 
kD forms of ld and sd NCAM are present in similar concen- 
trations to the MSD-negative 180- and 145-kD forms of ld 
and sd.  By 10 d, these MSD-positive forms are present at 
clearly higher concentrations than the corresponding MSD- 
negative forms. Similarly, the 120-kD MSD-negative form 
of ssd NCAM is present in 7-d tissue but is below detection 
thereafter,  while  the  125-kD  MSD-positive  form of ssd 
NCAM continues at high concentration throughout devel- 
opment. 
Spatial variations in the expression of forms of NCAM are 
also readily detected. Ventricular tissue (primarily myocar- 
dium) from 5-d embryos contain.~ a similar set of forms of 
NCAM (Fig. 9) to that observed in the 4- or 7-d heart (Fig. 
8). In contrast, atrioventricular cushion tissue from 5-d em- 
bryos contains primarily one form of NCAM,  the MSD- 
negative form of sd. It contains much less ld, ssd, or even 
the MSD-positive form of sd NCAM than does the ventricu- 
lar extract from the  same  stage  embryos.  Moreover, the 
small amount of MSD-positive sd present may result from 
myocardial contamination of the cushion tissue, given that 
cultured endocardial or mesenchymal cells contain only one 
form of NCAM, MSD-negative sd (Mironov, V., R. R. Mark- 
wald, and S. Hoffman, unpublished observations). Thus, the 
percentage of MSD-positive NCAM in heart tissue can vary 
from almost 0 to 100%, depending on the stage of develop- 
ment and region of the heart. 
NCAM Molecules Containing  the MSD Region 
Colocalize with Z  Discs 
To determine the distribution at the immunohistochemical 
Figure  9.  Endocardial  cushion 
tissue is deficient in GPI-linked 
and  MSD  region-containing 
forms of NCAM. Ventricles (V) 
and  cushion  tissue  (CT)  pads 
were dissected from 5-d chicken 
embryos. As described in Mate- 
rials and Methods, 5-/~g  Miquots 
of NP-40 extracts of membranes 
ware neuraminidase treated, then 
Western  blotted  using  the pan- 
NCAM antibody as the primary 
antibody for detection. Small arrows on the left indicate the forms 
of NCAM (155, 125, and 120 kD) present at relatively high levels 
in the ventricle and low levels in cushion tissue; the large arrow on 
the right indicates the form of N-CAM (145 kD) present at rela- 
tively high levels in both samples. The migration of standard pro- 
teins is indicated by their relative molecular messes  ×  10  -3. 
level of NCAM molecules containing the MSD region, sec- 
tions of stage 18 embryonic heart tissue were stained using 
anti-12CD (Fig.  10). Anti-12AB was not useful in immuno- 
histochemical studies. As predicted from the results of Fig. 
9, the myocardium was stained with anti-12CD, while little 
or no staining was seen in the endocardium or endocardiai 
cushion tissue. When the myocardial portion of these sec- 
tions was observed at high magnification (Fig. 11), a striking 
subceilular distribution of NCAM molecules containin  S tile 
MSD  region  was  observed;  staining  with  anti-12CD  ap- 
peared to coincide with the position of Z discs. This staining 
was specific; no staining was observed if the antibody was 
preincubated with the peptide used to produce anti-12CD 
(Fig.  11 b), and no staining was observed with nonimmune 
IgG (Fig.  11 f). Although anti-NCAM antibodies did stain 
the surface of  myocardial ceils, they did not highlight Z discs 
(Fig.  11 c). Other adhesion molecules, N-cadherin and/~l- 
integrin, have previously been shown to be associated with 
Z discs later in development (Hilenski et al.,  1992; Knud- 
sen, K. A., personal communication). We examined the ex- 
pression of these proteins in stage  18 myocardium; while 
both molecules were present, neither N-cadherin (Fig. 11 d) 
Figure 14  Anti-12CD immunostaining of the  stage  18 chicken 
heart. Anti-12CD immunostaining was detected in the myocardium 
(M), whereas little staining was revealed in either endocardium (E) 
or in cushion mesenchyme (CM). Bar, 100 ~m. 
Byeon et el. Association of MSD Containing NCAM with Z Discs  215 Figure 11. Comparative immunostaining of different adhesion molecules in the stage 18 chicken heart. (a) High magnification photomicro- 
graph depicts a striking subeellular distribution of  anti-12CD staining (arrowheads) that coincides with the position of Z discs. (b) A section 
adjacent to that shown in a in which anti-12CD was preabsorbed with the immunogenic peptide as described in Materials and Methods. 
Note that this treatment prevented the immunostaining seen in a. (c) Immunostaining with the pan-NCAM antibody was localized at the 
periphery of the myocardial cells. (d) Anti-N-cadherin (NCD-2) irnmunostaining was found in a punctate pattern at the periphery of the 
myocardial cells. (e) Anti-131-integrin (V2E9) immtmostaining labeled the cell periphery. Similar results were obtained with anti-131 integrin 
antibody JG22.  (f) No staining was observed with nonimmune rabbit IgG. Bar,  10 tLm. 
nor 151-integrin (Fig.  11 e) colocalized with Z  discs. Thus, 
at this early stage in development, NCAM molecules con- 
taining the MSD region appear to colocalize with Z  discs, 
while N-cadherin, 131-integrin, and NCAM molecules lack- 
ing the MSD region do not exhibit this specific association. 
Confocal  microscopy was  used  to  further  compare the 
localization of Z  discs and forms of NCAM.  When tissue 
sections were double labeled using anti-12CD and anti-cx- 
actinin (a marker for Z  discs), an almost complete coinci- 
dence between  the  two  signals  was observed (Fig.  12,  a 
versus b).  In two regions (indicated by brackets), periodic 
anti-a-actinin staining was observed, but no staining with 
anti-12CD. These observations suggest that most Z discs in 
these cells are located close to the cell surface in the same 
confocal section (thickness <0.25/~m) as the MSD region- 
containing NCAM on the cell surface. Only the occasional 
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or anti-12CD and anti-NCAM. Double immunostaining routinely reveals a coincidence between anti-12CD (a, arrowheads) and a-actimn 
(b, arrowheads) staining in association with Z discs. Occasionally anti-o~-actinin  staining is observed in the absence of anti-12CD staining 
(compare brackets in a and b). In contrast, there is only limited overlap between anti-12CD staining (c) and staining with the pan-NCAM 
antibody (d). Cells in which the plane of focus captured the cell surface (regions between broken lines) showed almost uniform staining 
with the pan-NCAM antibody (d), whereas anti-12CD staining appeared in the characteristic pattern (c). Cells cut in equatorial section 
(asterisks inside) showed almost uniform circumferential staining with the pan-NCAM antibody (d) and frequently show periodic circum- 
ferential staining with anti-12CD (c). Bar,  10 #m. 
set of Z discs is located either deeper in the cell, or it is not 
associated  with  NCAM  molecules  containing  the  MSD 
region. 
When tissue sections were double labeled using anti-12CD 
and the pan-NCAM antibody, cells in which the plane of fo- 
cus captured the cell surface showed almost uniform staining 
with the pan-NCAM antibody, whereas anti42CD staining 
appeared in  the  characteristic  striped pattern  (Fig.  12,  c 
versus d,  regions between broken lines).  Only at scattered 
sites did the pan-NCAM antibody show any hint of  highlight- 
ing  NCAM  molecules associated with Z  discs.  Similarly, 
cells in which the plane of focus cut an equatorial section 
(Fig.  12,  c and d, asterisks inside) showed circumferential 
staining that was relatively uniform with the pan-NCAM an- 
tibody  and  that  was  frequently periodic  with  anti-12CD. 
These results strongly suggest that NCAM molecules con- 
talning the MSD region are colocalized with Z discs, while 
NCAM molecules lacking the MSD region are uniformly 
distributed over the entire cell surface. 
Despite the fact that the anti-12CD antibody recognizes 
only NCAM in Western blotting experiments, we were con- 
cemed that it might recognize an additional protein in im- 
munohistochemical  studies.  To  rule  out  this  possibility, 
tissue  sections were sequentially incubated with the pan- 
NCAM antibody and anti-12CD antibodies.  This pretreat- 
ment with the pan-NCAM antibody totally blocked anti-12CD 
staining (data not shown), indicating that the pan-NCAM an- 
tibody  and  anti-12CD  recognize  the  same  protein,  i.e., 
NCAM. 
Structures known as costameres have been identified (Pardo 
et al.,  1983) in which cell surface proteins appear to be 
linked to Z discs by vinculin. However, when we examined 
the distribution of vinculin in tissue sections from stage 18 
myocardium, the staining patterns observed did not coincide 
Byeon et al. Association of MSD Containing  NCAM with Z Discs  217 Figure 13. Confocal microscopic observation of cultured stage 18 myocardial  cells stained with anti-12CD. Anti-12CD staining of cultured 
stage 18 myocardial cells is associated with Z discs. Bar, 10 t~m. 
with the patterns obtained with anti-12CD or anti-c~-actinin 
(data not shown). Because previous studies of costameres 
were performed later in development, it is likely that the as- 
sociation of vinculin with Z  discs has not yet occurred at 
stage 18. 
The anti-12CD staining pattern was also examined in cul- 
tured stage 18 myocardial cells. As in vivo, anti-12CD stain- 
ing was in register with Z discs (Fig. 13). Moreover, the fact 
that this staining pattern is exhibited by isolated cells sug- 
gests that the maintenance of this pattern does not depend on 
cell-cell adhesion. 
Discussion 
We have prepared antibodies against two oligopeptides (12AB 
encoded by exons 12A and 12B;  12CD  encoded by exons 
12C and 12D) that together comprise the entire alternatively 
spliced MSD region in the extraceUular portion of chicken 
NCAM. Using these antibodies, we have made the following 
novel observations: (a) All three splice variants of NCAM 
lid, sd, and ssd) that differ in their mode of attachment to 
the plasma membrane are expressed during heart develop- 
ment both in forms that contain and in forms that lack the 
MSD region. (b) At the protein level, the MSD region en- 
coded by exons 12A,  1213, 12C, and 12D appears either to 
be absent or to be expressed in its entirety, i.e., we see no 
evidence for alternate splicing among these four small exons. 
(c)  The six forms of NCAM detected in this study each 
change dramatically in their expression during development. 
In particular, the percentage of the ld, sd, or ssd form ex- 
pressed that is also MSD region positive can vary between 
0 and 100% in a temporally and spatially controlled manner. 
(d) At the immtmohistoehemical  level, forms of NCAM con- 
taining the MSD region are specifically associated with Z 
discs early in heart development, suggesting a role for this 
region of NCAM in myofibrillogenesis. 
Our previous studies on forms of NCAM expressed in the 
developing chicken heart revealed 180-, 150-, 140-, and 130- 
kD  polypeptides (Prediger  et al.,  1988;  Hotfrnan et  al., 
1990).  The 130-kD polypeptide was found to be GPI linked 
to the plasma membrane and to be the predominant form of 
NCAM in adult heart, while the 150- and 140-kD forms were 
predominant earlier in development. In the current study, we 
have been able to resolve and unambiguously identify six 
forms of  NCAM during heart development. 185- and 180-kD 
polypeptides have been shown to be variants of the large cy- 
toplasmic domain form of NCAM because the are recog- 
nized by monoclonal antibody 4d. 125- (previously referred 
to as 130) and 120-kD polypeptides are variants of the small 
surface domain form of NCAM as evidenced by the fact that 
they are released from membranes by PIPLC. 155- and 145- 
(previously referred to as 150 and 140) kD polypeptides are 
variants of the small cytoplasmic domain form of NCAM. 
In each of these pairs, the higher molecular mass forms (185, 
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bodies, while the lower molecular mass forms (180, 145, and 
120 kD) are not recognized by these antibodies. Thus, each 
splice variant of NCAM that differs in its attachment to the 
plasma membrane can also be expressed either containing or 
lacking the MSD region. This interpretation  of the identity 
of NCAM polypeptides is in agreement with the studies of 
Yoshimi et al.  (1993) on the  155- and  145-kD forms  of 
NCAM expressed during skeletal muscle development. 
In previous studies of forms of NCAM expressed during 
heart development,  the ld form observed  was considered 
likely to be of neural origin.  The current study suggests, 
however, that the ld form of NCAM may be expressed by 
heart tissue. First of  all, the 185- and 180-kD forms of  NCAM 
are present at significant levels in 4-d embryos, and they peak 
in expression in 7-d embryos. If  these forms of NCAM were 
expressed by the innervation of the heart, they might be ex- 
pected to appear later and to be maintained throughout de- 
velopment.  Second, the 185-kD form of NCAM is recog- 
nized  by anti-MSD  region  antibo'dies, even though  these 
antibodies do not recognize any form of  NCAM in the brain. 
Assuming that the innervatinn of the heart is similar to the 
brain in not expressing forms of NCAM recognized by anti- 
MSD antibodies, then the data would suggest that at least the 
185-kD form of NCAM is produced within the heart. It is 
tempting to speculate that the ld form of  NCAM may be pref- 
erentially expressed in the conduction system, given that the 
polysialic moieties found on NCAM, as well as the carbohy- 
drate epitopos recognized by monoclonal  antibody HNK-1 
and found on NCAM and other neural adhesion molecules, 
are also preferentially expressed in this region of the heart 
(Watanabe et al.,  1992; Nakagawa et al.,  1993). 
Data from PCR amplification of cDNAs prepared  from 
developing rat heart mRNAs have suggested that alternative 
splicing occurs between exons 12A, 12B, 12C, and 12D, and 
that these four small exons are present together in only a 
small percentage  of NCAM mRNAs (Reyes etal.,  1991). 
Our results provide a very different picture for NCAM mole- 
cules at the protein level. Even at the level of CNBr frag- 
ments, we see that anti-12AB and and-12CD recognize the 
same polypeptide and that there is no apparent heterogeneity 
in the size of this polypeptide. Because exons 12A and 12D 
are very small, we may not have been able to detect their al- 
ternative splicing at the protein  level; however, we should 
have been able to detect alternative splicing of  exons 12B and 
12C because they encode sufficient mass (11  or 14 amino 
acids) to noticeably affect the migration of a 45-kD CNBr 
fragment. The PCR data of Reyes et al. (1991) indicate that 
~70%  of the NCAM mRNA obtained  from perinatal  rat 
hearts lacks both exons 1213 and 12C, and that only 8-15 % 
(depending on whether ld, sd, or ssd molecules are being 
considered) contains both 12B and 12C. In contrast,  at the 
protein level, we find that for ld, sd, and ssd NCAM, forms 
of  the molecule containing the MSD region represent ~>50% 
of the NCAM molecules present in the heart from 4-d em- 
bryos  through  adults.  Moreover,  the  great  majority  of 
NCAM molecules contain the MSD region in 10- and 14-d 
embryos and in adults. This difference between our results 
and the results of Reyes et al. (1991) may be caused by spe- 
cies differences, differences in message stability or the abil- 
ity of  messages to be translated, or to differences in the half- 
life of the various polypeptides. 
A striking difference in the regional expression of forms 
of NCAM containing and lacking the MSD region was seen 
in early heart development in both Western blotting and im- 
munohistochemical experiments. Extracts of atrioventricu- 
lar endocardial  cushion tissue  included very little NCAM 
containing  the MSD  region.  Moreover,  all  the MSD  re- 
gion-containing NCAM in these  samples may be derived 
from myocardial contamination; only the sd form of NCAM 
lacking the MSD region is present in cultured endocardial 
and mesenchymal cells (Mironov, V., R. R. Markwald, and 
S. Hoffman, unpublished observations). In contrast, extracts 
of ventricle showed equal levels of NCAM molecules con- 
taining and lacking the MSD region.  Similarly, immuno- 
histochemical analyses showed NCAM molecules contain- 
ing the MSD region to be present in the myocardium, but 
they were either absent or present at only low levels in tissues 
of endocardial origin. 
The subcellular distribution of NCAM molecules contain- 
ing the MSD  region  was even more striking.  Anti-12CD 
staining colocalized with the Z discs of myofibrils (detected 
by staining with anti-ct-actinin [sarcomeric]). Curiously, al- 
though the pan-NCAM antibody uniformly stained the cell 
surface, it showed little, if any, enhanced staining in register 
with Z discs. Nevertheless, it is clear that the structures rec- 
ognized by anti-12CD that colocalize with Z discs must be 
NCAM molecules containing the MSD region because anti- 
12CD staining is blocked by preincubation of the antibody 
with the peptide against which it was made or by preincuba- 
tion of the tissue section with the pan-NCAM antibody. 
Other adhesion molecules (namely Bl-integrin [Hilenski et 
al., 1992] and N-cadherin [Knudsen, K. A., personal com- 
munication]) have previously been localized to Z discs at later 
stages of development; however, we do not detect anti-/~l- 
integrin and anti-N-cadherin staining in association with Z 
discs at stage  18  when we do detect  anti-12CD staining. 
These observations make NCAM molecules containing the 
MSD region the earliest-appearing cell surface component 
to be detected in association with Z discs. Therefore, NCAM 
molecules containing the MSD region are particularly good 
candidate molecules to play a role in the initiation of myo- 
fibfillogenesis during early heart development. 
This study provides two striking insights regarding the role 
of MSD region-containing NCAM in cellular  interactions 
and in the mechanism of its linkage to the cytoskeleton.  (a) 
NCAM is well known to be a cell-cell adhesion molecule 
and is usually observed at sites of cell-cell contact in im- 
munohistological  studies.  Nevertheless,  our  observations 
raise the possibility that cell-cell adhesion does not play a 
role in the colocalization of MSD region-containing NCAM 
with Z discs.  In vivo, MSD  region-containing NCAM is 
localized in register with Z discs and not in a uniform distri- 
bution on the cell surface or in intercalated discs, as would 
be expected for a molecule involved in cell-cell adhesion. In 
vitro, MSD region-containing NCAM can become colocal- 
ized with Z discs in isolated cells where little, if any, of the 
cell surface is involved in cell-cell contact.  These observa- 
tions  raise  the  possibility  that  MSD  region-containing 
NCAM is involved in cell-ECM  adhesion.  This would be 
consistent with scanning electron microscopic  studies that 
show collagen-containing "struts" of connective tissue that 
interact with the myocardial cell surface in register with Z 
discs (Borg et al., 1985). (b) NCAM molecules containing 
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Figure 14. Models for the mechanism whereby NCAM containing 
the MSD region is specifically associated with Z discs. The MSD 
region and its covalenfly attached O-linked oligosaccharide is rep- 
resented by a filled  circle. Ligands recognizing the MSD region are 
depicted with a complementary shape.  (A) the interaction of an 
ECM ligand with the MSD region induces a conformational change 
in the cytoplasmic  tail of NCAM, allowing it to bind to the Z discs. 
NCAM molecules lacking the MSD region cannot bind this ECM 
ligand and, therefore, cannot undergo the conformational change 
that allows them to dock in Z discs. (B) A cis ligand (present in 
the plasma membrane of the same cell) binds both to the MSD re- 
gion and to the Z disc. NCAM molecules lacking the MSD region 
do not bind to this cis ligand and do not become associated with 
Z discs. 
the MSD region are identical in the primary structure of their 
cytoplasmic region with NCAM molecules lacking the MSD 
region.  Nevertheless,  the  MSD  region-containing  mole- 
cules appear to interact  with the cytoskeleton in a manner 
that results in their colocalization with Z discs, while mole- 
cules  lacking  the  MSD  region  do  not  interact  with  the 
cytoskeleton  in  this  manner.  This  suggests  two  models 
depicted  in  Fig.  14.  Either  the  interaction  of  MSD  re- 
gion-containing NCAM with an ECM ligand alters the con- 
formation of the cytoplasmic tail of NCAM, resulting in its 
ability to bind to a component Z discs (Fig.  14 A), or MSD 
region-containing NCAM molecules can interact with a pro- 
tein in the same cell (c/s ligand) that possesses the ability to 
bind to a component of Z discs (Fig. 14 B). Of course, more 
complicated models are also possible; for example, the inter- 
action of MSD region-containing NCAM with a cis ligand 
might induce the ability of the NCAM or of the cis ligand 
to interact  with Z discs. Whether MSD region-containing 
NCAM interacts with an ECM ligand or a cis ligand, the in- 
teractive portion of the MSD region may lie in its amino acid 
sequence  or in the  O-linked  carbohydrate  (recognized by 
peanut lectin after neuraminidase treatment of the molecule 
[see above and Walsh et al., 1989]) associated with the MSD 
region. 
The current study demonstrates the feasibility and utility 
of using antibodies against alternatively  spliced regions in 
NCAM to evaluate  their identity and distributions in vivo. 
The existence of the MSD  region in NCAM  was deduced 
from molecular biological  studies.  However,  such  studies 
did not indicate precisely which mRNAs detected on North- 
ern blots using MSD region-specific probes encode which 
NCAM polypeptides observed on Western blots. Molecular 
biological studies also did not and cannot indicate the subcel- 
lular distribution  of forms of NCAM containing the MSD re- 
gion. The antibodies prepared  in the current study have al- 
lowed the  identification  and  characterization  on  Western 
blots of the forms of NCAM  containing the MSD region. 
Moreover,  these  antibodies  have  allowed us  to make  the 
striking  observation  that  forms of NCAM  containing  the 
MSD  region are  colocalized  with  Z  discs  and,  thus,  are 
likely  to  be  involved  in  myofibrillogenesis.  Antibodies 
specific for other splice variants of NCAM (e.g., ld and ssd 
forms and forms containing the VASE insert) may be equally 
useful for determining the distribution  in vivo of particular 
forms of NCAM,  thereby  suggesting  specialized functions 
for each of these forms. 
Monoclonal antibodies 4d (specific for the ld form of NCAM, developed 
by U. Rutishauser, Case Western Reserve University, Cleveland, OH) and 
V2E9 and IG22  (each specific for the Bl-integrin suhunit, developed by 
A. Horwitz, University of Illinois, Urbana, IL, and D. Gottlieb, Washing- 
ton University, St. Louis, MO, respectively) were obtained from the De- 
velopmental Studies Hybridoma Bank, which is maintained by the Depart- 
ment of Pharmacology and Molecular Sciences, Johns Hopkins University 
School of Medicine, Baltimore,  MD,  and the Department of Biology, 
University of Iowa, Iowa City, IA, under contract N01-HD-2-3144 from 
the National Institute for Child Health and Human Development. Monoclo- 
hal antibody NCD-2 (specific for N-cadherin) was a gift from Dr. Jack 
Lilien (Clemson University, Clemson, SC). 
These studies were supported by U. S. Public Health Service grants R01 
HL37641 to S. Hoffman, R01 HL37156 to R. R. Markwald, and by a pro- 
gram project to R. R. Markwald. 
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